Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVT 301 MAO-B occupancy PET study in Alzheimer's disease and elderly controls
2006-001261-42Phase 2Completed
- Sponsor
- Evotec SE
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of EVT-301 in Alzheimer's disease (AD) (2 arms), sponsored by Evotec SE. Primary endpoints: Brain MAO-B occupancy and Steady-state trough concentration associated with target occupancy. Started Mar 2006; status: completed.
02
Drugs
EVT-301
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2006-001261-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001261-42.